日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Loss of RhoA in microglia disables glycolytic adaptation and impairs spinal cord injury recovery through Arhgap25/HIF-1α pathway.

小胶质细胞中 RhoA 的缺失会抑制糖酵解适应，并通过 Arhgap25/HIF-1α 通路损害脊髓损伤的恢复

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07947-9
Cai Jiale, Zheng Xinya, Luo Xiongbo, Cui Wenli, Ma Xinrui, Xu Shuyi, Fu Lanya, Zhang Jiaqi, Xu Yizhou, Li Yunlun, He Ye, Wang Xianghai, Guo Jiasong
细胞生物学
发表日期：2025
文献求助 收藏

Ershen Dan attenuates atherosclerosis by modulating the NOTCH1/NF-κB/NLRP3 signaling pathway to suppress M1 macrophage polarization.

二参丹通过调节 NOTCH1/NF-κB/NLRP3 信号通路抑制 M1 巨噬细胞极化，从而减轻动脉粥样硬化。

期刊:Chinese Medicine
影响因子:5.7
doi:10.1186/s13020-025-01232-9
Zhao Wenjie, Wang Hui, Peng Shijing, Wei Qing, Zhang Lei, Li Yunlun, Yang Wenqing
动脉粥样硬化
细胞生物学
巨噬细胞
OTC
LRP3
NLRP3
NOTCH
Notch1
Notch
巨噬细胞
发表日期：2025
文献求助 收藏

Combining Experimental Validation and Network Pharmacology to Reveal the Action Mechanism of Panax Notoginseng-Radix Salviae on Atherosclerosis

结合实验验证和网络药理学揭示三七对动脉粥样硬化的作用机制

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S508025
Song, Ningning; Zhang, Xinrong; Yin, Honglin; Zhang, Lei; Li, Chao; Li, Jian; Li, Yunlun; Wu, Jibiao
心血管
动脉粥样硬化
发表日期：2025
文献求助 收藏

Identification of Circulating Plasma Proteins as a Mediator of Hypertension-Driven Cardiac Remodeling: A Mediation Mendelian Randomization Study

循环血浆蛋白作为高血压驱动的心脏重塑介质的鉴定：一项中介孟德尔随机化研究

期刊:Hypertension
影响因子:8.2
doi:10.1161/HYPERTENSIONAHA.123.22504
Hu, Yuanlong; Lin, Lin; Zhang, Lei; Li, Yuan; Cui, Xinhai; Lu, Mengkai; Zhang, Zhiyuan; Guan, Xiuya; Zhang, Muxin; Hao, Jiaqi; Wang, Xiaojie; Huan, Jiaming; Yang, Wenqing; Li, Chao; Li, Yunlun
心血管
高血压
发表日期：2024
文献求助 收藏

Efficacy and Safety of Suxiao Jiuxin Pills in the Treatment of Chronic Coronary Syndrome with Intolerance to Adverse Effects of Long-acting Nitrates: A Multicenter, Randomized, Double-blind, Placebo-controlled Study

舒消九心丸治疗对长效硝酸酯类药物不良反应不耐受的慢性冠状动脉综合征患者的疗效和安全性：一项多中心、随机、双盲、安慰剂对照研究

期刊:BMC Complementary Medicine and Therapies
影响因子:3.4
doi:10.1186/s12906-024-04661-5
Hu, Yuanlong; Wang, Yifei; Wang, Shiqin; Cui, Xirong; Feng, Yong; Li, Zhengguang; Ji, Kegang; Wang, Jianming; Sun, Chenghua; Tang, Yan; Li, Yunlun
发表日期：2024
文献求助 收藏

Association of remnant cholesterol with frailty: findings from observational and Mendelian randomization analyses

残余胆固醇与衰弱的关联：观察性研究和孟德尔随机化分析的结果

期刊:Lipids in Health and Disease
影响因子:4.2
doi:10.1186/s12944-023-01882-4
Hu, Yuanlong; Wang, Xiaojie; Lin, Lin; Huan, Jiaming; Li, Yuan; Zhang, Lei; Li, Yunlun
代谢
发表日期：2023
文献求助 收藏

Effect of dietary inflammatory potential on the aging acceleration for cardiometabolic disease: A population-based study

饮食炎症潜能对心血管代谢疾病衰老加速的影响：一项基于人群的研究

期刊:Frontiers in Nutrition
影响因子:5.1
doi:10.3389/fnut.2022.1048448
Hu, Yuanlong; Wang, Xiaojie; Huan, Jiaming; Zhang, Lei; Lin, Lin; Li, Yuan; Li, Yunlun
炎症/感染
炎症
衰老
代谢
发表日期：2022
文献求助 收藏

Natural drugs targeting inflammation pathways can be used to treat atherosclerosis

靶向炎症通路的天然药物可用于治疗动脉粥样硬化。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2022.998944
Song, Xiayinan; Wang, Xiaoming; Wang, Danyang; Zheng, Zhenzhen; Li, Jie; Li, Yunlun
炎症
炎症/感染
信号转导
心血管
动脉粥样硬化
发表日期：2022
文献求助 收藏

Efficacy and safety of Tengfu Jiangya tablet combined with valsartan/amlodipine in the treatment of stage 2 hypertension: study protocol for a randomized controlled trial

腾福姜牙片联合缬沙坦/氨氯地平治疗2期高血压的疗效和安全性：一项随机对照试验的研究方案

期刊:Trials
影响因子:2
doi:10.1186/s13063-022-06089-z
Wang, Yu; Hua, Zhen; Chen, Wenjing; Zhu, Yushuo; Li, Yunlun
心血管
高血压
发表日期：2022
文献求助 收藏

Ginsenoside Rg1-Notoginsenoside R1-Protocatechuic Aldehyde Reduces Atherosclerosis and Attenuates Low-Shear Stress-Induced Vascular Endothelial Cell Dysfunction

人参皂苷 Rg1-三七皂苷 R1-原儿茶醛可减轻动脉粥样硬化并减轻低切应力引起的血管内皮细胞功能障碍

期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2020.588259
Lei Zhang, Yuan Li, Xin Ma, Jiali Liu, Xiaojie Wang, Lingxiao Zhang, Chao Li, Yunlun Li, Wenqing Yang
免疫
细胞生物学
动脉粥样硬化
内皮细胞
发表日期：2021
文献求助 收藏